Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Corrigendum to "Synergistic Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide and Sorafenib against Cancer Stem Cells, Anaplastic Thyroid Cancer" [Neoplasia 19 (2017) 145-153].
Neoplasia ( IF 4.8 ) Pub Date : 2017-07-26 , DOI: 10.1016/j.neo.2017.05.006 Ki Cheong Park 1 , Seok-Mo Kim 1 , Jeong Yong Jeon 2 , Bup-Woo Kim 1 , Hyeung Kyoo Kim 1 , HoJin Chang 1 , Yong Sang Lee 1 , Soo Young Kim 1 , Seung Hoon Choi 1 , Cheong Soo Park 1 , Hang-Seok Chang 1
中文翻译：
“ N-羟基-7-（2-萘硫基）庚酰胺和索拉非尼对癌干细胞，间变性甲状腺癌的协同活性”更正[Neoplasia 19（2017）145-153]。
更新日期：2019-11-01
Neoplasia ( IF 4.8 ) Pub Date : 2017-07-26 , DOI: 10.1016/j.neo.2017.05.006 Ki Cheong Park 1 , Seok-Mo Kim 1 , Jeong Yong Jeon 2 , Bup-Woo Kim 1 , Hyeung Kyoo Kim 1 , HoJin Chang 1 , Yong Sang Lee 1 , Soo Young Kim 1 , Seung Hoon Choi 1 , Cheong Soo Park 1 , Hang-Seok Chang 1
Affiliation
中文翻译：
“ N-羟基-7-（2-萘硫基）庚酰胺和索拉非尼对癌干细胞，间变性甲状腺癌的协同活性”更正[Neoplasia 19（2017）145-153]。
京公网安备 11010802027423号